Collegium Pharmaceutical Inc Announces U S Patent Issued Covering its DETERx TM Abuse Deterrent Sustained Release Technology: related news

Collegium Pharmaceutical Inc. Announces U.S. Patent Issued Covering its DETERx(TM) Abuse Deterrent Sustained Release Technology

CUMBERLAND, R.I.--(BUSINESS WIRE)--July 16, 2008 - Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that a new patent has been issued by the U.S. Patent and Trademark Office (USPTO) relating to its tamper resistant, abuse-deterrent formulation platform. US Patent Number 7,399,488 contains claims that cover orally administrable compositions comprising Collegium's proprietary micro-particle formulations. The formulations are designed to be more resistant to physical methods of tampering than currently available sustained release dosage forms. US Patent No. 7,399,488 will provide protection for DETERx(TM) and products incorporating the DETERx(TM) technology into the year 2025.

Collegium Pharmaceutical Inc. Announces U.S. Patent Issued Covering its DETERx(TM) Abuse Deterrent Sustained Release Technology

Collegium Pharmaceutical Inc. Announces U.S. Patent Issued Covering its DETERx(TM) Abuse Deterrent Sustained Release Technology

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling...

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill) CAMARILLO, Calif., Aug. 19 /PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent. The U.S. Patent Office accepted all key aspects of the company's patent application. "We are pleased to receive this Notice of Allowance because it serves to protect the intellectual property and proprietary technology that we have developed," says Stephen Diehl, President and CEO of Surfware.

Santarus Announces Issuance Date of Additional U.S. Patent Covering Zegerid Products

SAN DIEGO--(BUSINESS WIRE)--Jul 8, 2008 - Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company, today announced that its licensor, the University of Missouri, has received an Issue Notification from the U.S. Patent and Trademark Office (USPTO) indicating that U.S. patent application number 10/641,732 will issue on July 15, 2008 as U.S. patent number 7,399,772. The new patent has claims covering methods for treating acid-caused gastrointestinal disorders by administering a solid pharmaceutical composition comprising non-enteric coated omeprazole and certain antacids. A Notice of Allowance was sent by the USPTO in April 2008. The new patent will have a July 2016 expiration date.

U.S. Patent on Cytori's Celution System Technology Issued; Celution System Commercialization not Impacted by Recent 6,777,231 Patent Inventorship Decision

SAN DIEGO--(BUSINESS WIRE)--Jun 24, 2008 - U.S. Patent No. 7,390,484 ("the '484 patent") covering Cytori's (NASDAQ:CYTX) Celution(R) System technology was issued today by the United States Patent and Trademark Office. The '484 patent provides Cytori critical market protection for its commercialization of the Celution System in the United States, where the Company is seeking regulatory approval. The '484 patent also protects Cytori's rights to manufacture the Celution Systems in the United States for commercialization into all markets, including Europe and Asia-Pacific, where the device is currently being sold. Other related patent filings are in progress around the globe.

Cephalon Announces Issuance of Patent for AMRI...

FRAZER, Pa., June 17 /PRNewswire-FirstCall/ -- Cephalon, Inc. (NASDAQ:CEPH) announced today that the U.S. Patent and Trademark Office has issued a pharmaceutical formulation patent for AMRIX(R) (Cyclobenzaprine Hydrochloride Extended-Release Capsules). U.S. Patent No. 7,387,793 was issued to Eurand Inc., the developer of AMRIX, and expires on February 26, 2025. Last year, Cephalon acquired an exclusive license from Eurand to market AMRIX in North America. The issued claims cover Eurand's proprietary Diffucaps(R) technology used to formulate AMRIX as an extended-release capsule containing the muscle relaxant cyclobenzaprine. The AMRIX formulation allows, for the first time, a full day of cyclobenzaprine in a single dose medication for the treatment of acute painful musculoskeletal conditions.

Santarus Announces Issuance Date of Additional U.S. Patent

Santarus, Inc. SNTS, a specialty pharmaceutical company, today announced that its licensor, the University of Missouri, has received an Issue Notification from the U.S. Patent and Trademark Office (USPTO) indicating that U.S. patent application number 10/641,732 will issue on July 15, 2008 as U.S. patent number 7,399,772. The new patent has claims covering methods for treating acid-caused gastrointestinal disorders by administering a solid pharmaceutical composition comprising non-enteric coated omeprazole and certain antacids. A Notice of Allowance was sent by the USPTO in April 2008. The new patent will have a July 2016 expiration date.

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill)

CAMARILLO, Calif., Aug. 19 /PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent. The U.S. Patent Office accepted all key aspects of the company's patent application. "We are pleased to receive this Notice of Allowance because it serves to protect the intellectual property and proprietary technology that we have developed," says Stephen Diehl, President and CEO of Surfware. "The mathematics and science behind Engagement Milling are revolutionary, and we have incorporated that technology into our SURFCAM product line as TrueMill(R).

Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)

announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assignee, Supernus Pharmaceuticals, Inc. The '978 patent covers the Company's approved product, SANCTURA XR(TM), a once-a-day formulation of trospium chloride which is indicated for the treatment of symptoms of an overactive bladder. Based on calculations made by the United States Patent and Trademark Office, the term of the '978 patent is twenty years plus 89 days from its filing date of November 4, 2004, or February 1, 2025. In September 2007, the Company entered into an agreement with Allergan, Inc. by which the Company granted Allergan an exclusive sublicense to market SANCTURA XR in the United States.

Silence Therapeutics Announces Successful Opposition of Glover Patent

a leading European RNA interference (RNAi) focused biotechnology company, announced today the successful opposition of a fundamental Alnylam Pharmaceuticals, Inc. European patent resulting in the patent being revoked in its entirety. The Opposition Division of the European Patent Office, following a three day hearing, announced its decision to revoke European Patent EP 1 230 375, exclusively licensed to Alnylam Pharmaceuticals from Cancer Research Technology, Ltd (UK). The Patent, commonly referred to as the "Glover" patent, broadly relates to medicaments comprising an RNA interference mediating RNA molecule. Opposition briefs to the Glover patent had been filed by Silence Therapeutics AG, Sanofi-Aventis Deutschland GmbH, Quark Biotech, Inc.

Techalt, Inc. Announces U.S. Patent Office Grants Petition to Revive Review of the Patent Application for Stan's Rodeo Ointment (''SRO'')

Techalt, Inc. Announces U.S. Patent Office Grants Petition to Revive Review of the Patent Application for Stan's Rodeo Ointment (''SRO'')

Alnylam Loses Challenge In Europe On Key Patent Covering Gene-Silencing Technology

July 14, 2008 (FinancialWire) Shares of Alnylam Pharmaceuticals Inc. (NASDAQ: ALNY) fell after the company said that it lost a challenge in Europe on a key patent which covered certain areas of its gene-silencing technology. Alnylam said claims on the "Glover" patent were overturned by the Opposition Division of the European Patent Office. The patent is licensed from Cancer Research Technology Ltd. and Alnylam said it plans to appeal the decision. Alnylam said that the decision does not alter the position of the company's intellectual property for developing and commercializing RNAi therapeutics, nor does it impact any ongoing business development discussions. The patent is one of 11 held by Alnylam. The goal of gene-silencing, or RNA-based, treatments is to turn off, or silence- the gene at the root of a medical condition, treating the a

Surfware Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill)

Surfware Inc. (Camarillo, CA) announces that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent.

Indevus Pharmaceuticals Announces Issuance of U.S. Patent for SANCTURA XR(TM)

PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. (Nasdaq: IDEV) announced today the issuance of U.S. Patent No. 7,410,978 (the "'978 patent"), entitled "Once Daily Dosage Forms of Trospium," which is licensed exclusively to the Company by the patent's assignee, Supernus Pharmaceuticals, Inc.

MDdatacor Receives Notice of Allowance for Patent on Technology from U.S. Patent Office

PRNewswire/ -- MDdatacor, Inc., a leader in health care quality management solutions for health plans and providers, today announced it has received a notice of allowance on a patent from the U.S. Patent Office for a key component of the company's proprietary CareInformatix(TM) technology platform.

Option Skews - Canadian Solar Inc, Rambus Inc, eBay Inc, VMware, Inc, DryShips Inc, MBIA Inc, CIENA Corp, Sun Microsystems

Companies seeing a skew towards puts in the previous session: Barrick Gold (ABX), PowerShares QQQ Trust (QQQQ), Fannie Mae (FNM), FREDDIE MAC (FRE), DIAMONDS Trust Series I (DIA), Sun Microsystems (JAVA), HSBC, plc. (HBC), Merrill Lynch & Co. (MER), Home Depot (HD), Teva Pharmaceutical Industries (TEVA), CIGNA Corp. (CI), MBIA (MBI), eBay Inc (EBAY), American International Group (AIG), Office Depot (ODP), Autodesk (ADSK), Dell (DELL), Hudson City Bancorp (HCBK), Southwestern Energy (SWN), Costco Wholesale (COST), DryShips Inc. (DRYS), Jabil Circuit (JBL), AutoNation (AN), Kraft Foods (KFT), Morgan Stanley (MS).

Encore Networks Announces the Issuance of a U.S. Patent Relating to its Selective Layer Encryption for Broadband Satellite Networks

Encore Networks, a leading supplier of industrially hardened VPN based network security appliances, today announced that it has been granted a patent by the U.S. Patent and Trademarks Office under U.S. Patent Number 7,360,083. This patent relates to Encore’s innovative method for providing security solutions to aid protocol acceleration over satellite networks using Selective Layer Encryption (SLE). SLE is an encryption technology that securely connects satellite networks with terrestrial links as part of an end-to-end Virtual Private Network (VPN) solution.

Applied Nanotech Holdings, Inc. (Formerly Nano-Proprietary, Inc.) Announces New Trading Symbol

AUSTIN, TX, Jul 01 (MARKET WIRE) -- Applied Nanotech Holdings, Inc. (OTCBB: APNT) announced that its new trading symbol is effective with the start of trading today. The new symbol is required as a result of the change in the Company's name. This new symbol was assigned by NASDAQ, operator of the OTC Bulletin Board. Shareholders that hold shares in certificate form do not need to take any action. Existing certificates with the name Nano-Proprietary, Inc. on them will still represent ownership in Applied Nanotech Holdings, Inc. ABOUT APPLIED NANOTECH HOLDINGS, INC. Applied Nanotech Holdings, Inc., formerly Nano-Proprietary, Inc., is a holding company consisting of two wholly owned operating subsidiaries. Applied Nanotech, Inc. is a premier research and commercialization organization dedicated to developing applications for nanotechnology w

Wi-LAN adds LG to its patent lawsuit

Intellectual property holder Wi-LAN Inc. has added LG Electronics Inc. of South Korea to patent litigation it previously filed against Research In Motion Ltd., Motorola Inc. and UTStarCom Inc. Wi-LAN, which launched the original suit in Texas on June 20, claims that all the defendants have infringed and continue to infringe on two U.S. patents it holds related to mobile handheld devices and other equipment. Wi-LAN, which has a stock market value of about $180-million compared with RIM's $67.7-billion and Motorola's $16-billion (U.S.), holds about 300 issued or pending patents, ranging from the television content filtering V-chip to an array of wireless telecommunications technologies. The amended lawsuit in U.S. District Court for the Eastern District of Texas adds LG Electronics Inc.

Wi-LAN adds LG to its patent lawsuit

Intellectual property holder Wi-LAN Inc. has added LG Electronics Inc. of South Korea to patent litigation it previously filed against Research In Motion Ltd., Motorola Inc. and UTStarCom Inc. Wi-LAN, which launched the original suit in Texas on June 20, claims that all the defendants have infringed and continue to infringe on two U.S. patents it holds related to mobile handheld devices and other equipment. Wi-LAN, which has a stock market value of about $180-million compared with RIM's $67.7-billion and Motorola's $16-billion (U.S.), holds about 300 issued or pending patents, ranging from the television content filtering V-chip to an array of wireless telecommunications technologies. The amended lawsuit in U.S. District Court for the Eastern District of Texas adds LG Electronics Inc.

Wi-LAN adds LG to its patent lawsuit

Intellectual property holder Wi-LAN Inc. has added LG Electronics Inc. of South Korea to patent litigation it previously filed against Research In Motion Ltd., Motorola Inc. and UTStarCom Inc. Wi-LAN, which launched the original suit in Texas on June 20, claims that all the defendants have infringed and continue to infringe on two U.S. patents it holds related to mobile handheld devices and other equipment. Wi-LAN, which has a stock market value of about $180-million compared with RIM's $67.7-billion and Motorola's $16-billion (U.S.), holds about 300 issued or pending patents, ranging from the television content filtering V-chip to an array of wireless telecommunications technologies. The amended lawsuit in U.S. District Court for the Eastern District of Texas adds LG Electronics Inc.

Supreme Court strengthens patent exhaustion doctrine

The United States Supreme Court has unanimously held in Quanta Computer, Inc. v. LG Electronics, Inc. that the patent law cannot be used to control the subsequent use or disposition of a product "that substantially embodies a patent" once the product has been sold with authority of the patent owner. "The authorized sale of an article that substantially embodies a patent exhausts the patent holder's rights and prevents the patent holder from invoking the patent law to control post-sale use of the article." Patent exhaustion applies whether the patents are directed to products or methods. "Our precedents do not differentiate transactions involving embodiments of patented methods or processes from those involving patented apparatuses or materials.

Zacks Analyst Blog Highlights: Trident Microsystems, Inc., Sony, American Axle &...

Zacks Analyst Blog Highlights: Trident Microsystems, Inc., Sony, American Axle & Manufacturing Holdings Inc., D.R. Horton, Inc. and Cache, Inc. www.profits.zacks.com/ CHICAGO--(Business Wire)-- Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Trident Microsystems, Inc. (NASDAQ: TRID), Sony (NYSE: SNE), American Axle & Manufacturing Holdings Inc (NYSE: AXL), D.R. Horton, Inc. (NYSE: DHI) and Cache, Inc. (NASDAQ: CACH). Get the most recent insight from Zacks Equity Research with the free Profit from the Pros newsletter: at.zacks.com/?id=4579 Here are highlights from Wednesday's Analyst Blog: Trident Micro Pressured in Asia Trident Microsystems, Inc.

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill)

PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent.

Surfware, Inc. Announces U.S. Patent Office Notice of Allowance for Engagement Milling (TrueMill)

PRNewswire/ -- Surfware, Inc., developer of innovative CAD/CAM software for machining, announced today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office (USPTO) for its Engagement Milling technology. A Notice of Allowance signifies that the application has been examined and is allowed for issuance as a patent.

Search took 1.35 seconds.